missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 18098494

TACI/TNFRSF13B/CVID Antibody (166010), DyLight 405, Novus Biologicals™

Rat Monoclonal Antibody

Brand:  Bio-Techne FAB1041E

Product Code. 18098494

  • € 904.00 / 0.50mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

TACI/TNFRSF13B/CVID Monoclonal antibody specifically detects TACI/TNFRSF13B/CVID in Mouse samples. It is validated for Western Blot, Flow Cytometry, ELISA (Matched Antibody Pair)
TRUSTED_SUSTAINABILITY
Specifications

Specifications

TACI/TNFRSF13B/CVID
Monoclonal
DyLight 405
CD267, CD267 antigen, CVID, CVID2, FLJ39942, MGC133214, TACIMGC39952, TNFRSF14B, Transmembrane activator and CAML interactor, tumor necrosis factor receptor 13B, tumor necrosis factor receptor superfamily member 13B, tumor necrosis factor receptor superfamily, member 13B
Mouse myeloma cell line NS0-derived recombinant mouse TACI/TNFRSF13B, Phe5-Thr129, Accession # Q9ET35
0.5 mL
Apoptosis, B Cell Development and Differentiation Markers, Signal Transduction
23495
Store at 4°C in the dark.
IgG2a
Western Blot, Flow Cytometry, ELISA
166010
50mM Sodium Borate
Rat
Protein A or G purified from hybridoma culture supernatant
RUO
Primary
Mouse
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.